Trust CO Of Oklahoma Novo Nordisk A S Transaction History

Trust CO Of Oklahoma

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$122.71 - $146.91 $2,699 - $3,232	-22 Reduced 1.06%	2,053 $293,000
Q1 2024 Apr 19, 2024	SELL	$102.11 - $135.92 $40,844 - $54,367	-400 Reduced 16.16%	2,075 $266,000
Q4 2023 Jan 22, 2024	SELL	$87.78 - $105.45 $81,196 - $97,541	-925 Reduced 27.21%	2,475 $256,000
Q3 2023 Oct 16, 2023	BUY	$90.94 - $199.54 $309,196 - $678,436	3,400 New	3,400 $309,000
Q4 2022 Jan 18, 2023	SELL	$102.55 - $135.33 $76,912 - $101,497	-750 Reduced 33.33%	1,500 $0
Q3 2022 Oct 11, 2022	SELL	$95.28 - $116.93 $71,460 - $87,697	-750 Reduced 25.0%	2,250 $224,000
Q3 2021 Oct 08, 2021	SELL	$84.42 - $106.62 $168,840 - $213,240	-2,000 Reduced 40.0%	3,000 $288,000
Q1 2020 Apr 16, 2020	SELL	$49.46 - $64.78 $34,473 - $45,151	-697 Reduced 12.23%	5,000 $301,000
Q4 2019 Jan 24, 2020	BUY	$49.86 - $58.26 $34,752 - $40,607	697 Added 13.94%	5,697 $329,000
Q3 2017 Oct 12, 2017	BUY	$41.15 - $49.22 $205,750 - $246,100	5,000	5,000 $0

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Trust CO Of Oklahoma, based on Form 13F filings with the SEC.

Stay updated on Trust CO Of Oklahoma with notifications on news.